Loading organizations...
§ Private Profile · Palo Alto, CA, USA
VyncaCare is a technology company.
VyncaCare delivers integrated solutions for serious illness care, encompassing home-based palliative care, comprehensive care navigation, and specialized software platforms. The company provides a unified system for serious illness management and advance care planning, complemented by direct services like Enhanced Care Management and specialty palliative care, which blend interdisciplinary support with intelligent technology to personalize patient care.
The company, originally named Vynca, was established in 2013 by Dr. Ryan Van Wert. His foundational insight stemmed from the critical necessity for advanced technology and robust analytics to enable patients and healthcare providers to accurately document and efficiently share crucial end-of-life and serious illness care preferences. Dr. Van Wert led the organization from its inception until Dr. Darren Schulte assumed the CEO role in 2023.
VyncaCare primarily serves patients, alongside healthcare providers and health plans, striving to offer person-centered care that optimizes comfort and control for individuals with serious illnesses. The company’s overarching vision is to facilitate "More Quality Days at Home™" for patients, aiming to reduce hospitalizations and enhance overall health outcomes through improved care coordination and compassionate support.
VyncaCare has raised $70.3M across 3 funding rounds.
VyncaCare has raised $70.3M in total across 3 funding rounds.
VyncaCare has raised $70.3M in total across 3 funding rounds.
VyncaCare's investors include Questa Capital, 4100 Group, First Trust, Generator Ventures, OCA Ventures, Autism Impact Fund, Deerfield Management, Rachel Kern, Scott Lancaster, Ziegler Link-Age Fund.
VyncaCare has raised $70.3M across 3 funding rounds. Most recently, it raised $30.0M Other Equity in January 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 31, 2022 | $30M Venture Round | Questa Capital | 4100 Group, First Trust, Generator Ventures, OCA Ventures | Announced |
| Jan 1, 2022 | $30M Series C | Questa Capital | Autism Impact Fund, Deerfield Management, 4100 Group, First Trust, Generator Ventures, OCA Ventures | Announced |
| Jun 19, 2019 | $10.3M Series B | — | Rachel Kern, Generator Ventures, OCA Ventures, Scott Lancaster, Ziegler Link AGE Fund | Announced |
VyncaCare is a health technology company that delivers person-centered palliative care and serious illness management through a hybrid model of in-home visits, virtual support, and AI-powered software. It serves patients with life-limiting illnesses, their families, healthcare providers, and payers by solving gaps in advance care planning, symptom management, and care coordination to enable more quality days at home and reduce avoidable hospitalizations.[1][2][4] Originally focused on advance care planning software, VyncaCare has grown into a comprehensive provider, operating in multiple U.S. states with predictive tech that monitors patient data for early interventions; it has raised over $40 million in funding and continues expanding geographically.[1][3]
VyncaCare originated in 2013 when it was founded in Palo Alto, California, by clinicians including co-founder Ryan Van Wert, M.D., with a vision to simplify advance care planning for seriously ill patients through digital software for creating, storing, and sharing goals-of-care documents integrated into electronic medical records.[1][2][3] The idea emerged from observing inconsistencies in end-of-life care wishes, leading to nationwide adoption by hospitals and clinics serving millions.[1] A pivotal shift occurred in 2021 with the acquisition of ReSolutionCare—a virtual-first palliative care practice founded in 2014 by Michael Fratkin, M.D., in Northern California—prompting expansion into direct clinical services.[1][3] The company rebranded to VyncaCare in 2022 to reflect its hybrid care model, began serving Oregon, Washington, Utah, and Idaho that year, and appointed Darren Schulte, M.D., as CEO in 2023, succeeding Van Wert, amid further growth into four western states.[1][3]
VyncaCare stands out in palliative care through its integrated tech-clinical model:
VyncaCare rides the wave of value-based care and home health expansion, addressing palliative shortages amid aging populations and rising chronic illness costs, where traditional models fail to deliver longitudinal, proactive support.[1][3][5] Timing aligns with post-pandemic telehealth acceleration and AI adoption in healthcare, enabling scalable interventions that cut ER/hospital use—key as payers prioritize outcomes over volume.[2][5] Market forces like Medicare Advantage growth and serious illness prevalence favor its model, influencing the ecosystem by pioneering AI-orchestrated palliative tech that integrates with EHRs and sets standards for hybrid, person-centered care beyond acute settings.[3][5][7]
VyncaCare is poised for rapid scaling, targeting 5-7 additional southern and midwestern states within the next year via its tech-driven model, with AI agents automating admin tasks to boost clinician efficiency.[1][5] Trends like predictive analytics maturation and payer demands for de-escalation will propel growth, potentially deepening partnerships with risk-bearing entities. Its influence may evolve from software pioneer to national palliative leader, redefining serious illness care for sustained quality-of-life gains—echoing its founding mission of wish-aligned, home-based support.[1][3][5]